Search Results - "Van Dyke, Gregory"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Poliosis overlying a nevus with blue nevus features by Young, Lorraine C, Van Dyke, Gregory S, Lipton, Shira, Binder, Scott W

    Published in Dermatology online journal (28-02-2008)
    “…Poliosis is a localized patch of gray or white hair. Because it can be seen with a variety of disorders and drugs, a full history and exam is indicated…”
    Get full text
    Journal Article
  2. 2

    Highly Purified 1000‐cSt Silicone Oil for Treatment of Human Immunodeficiency Virus‐Associated Facial Lipoatrophy: An Open Pilot Trial by Jones, Derek H., Carruthers, Alastair, Orentreich, David, Brody, Harold J., Lai, Mei‐Ying, Azen, Stanley, Van Dyke, Gregory S.

    Published in Dermatologic surgery (01-10-2004)
    “…Background. Among human immunodeficiency virus‐infected individuals, facial lipoatrophy has become epidemic. Those affected are stigmatized, leading to…”
    Get full text
    Journal Article
  3. 3

    CD30 positive anaplastic large-cell lymphoma mimicking Langerhans cell histiocytosis by Ezra, Navid, Van Dyke, Gregory S., Binder, Scott W.

    Published in Journal of cutaneous pathology (01-07-2010)
    “…The presence of CD 1a+ dendritic cells (DC) has been well described in T‐cell lymphoproliferative disorders, and the presence of large numbers of DCs has…”
    Get full text
    Journal Article
  4. 4

    Update on pathogenesis and treatment of acne by Lee, Delphine J, Van Dyke, Gregory S, Kim, Jenny

    Published in Current opinion in pediatrics (01-08-2003)
    “…Acne vulgaris is a common cutaneous disorder of the pilosebaceous follicle. More than 45 million people are affected with acne vulgaris. In addition, 80% of…”
    Get full text
    Journal Article
  5. 5

    An Anti-CD45RO Immunotoxin Eliminates T Cells Latently Infected with HIV-1 in vitro by McCoig, C, Van Dyke, G, Chou, C S, Picker, L J, Ramilo, O, Vitetta, E S

    “…Despite the success of highly active antiretroviral therapy (HAART) in lowering circulating HIV-1 to undetectable levels in most infected individuals, several…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection by Borvak, J, Chou, CS, Bell, K, Van Dyke, G, Zola, H, Ramilo, O, Vitetta, ES

    Published in The Journal of immunology (1950) (15-09-1995)
    “…The present studies were designed to further determine whether the CD25 marker could distinguish between cells productively and latently infected with HIV…”
    Get full text
    Journal Article
  11. 11

    The Use of Cyclosporine, FK506, and SDZ NIM811 to Prevent CD25 Quiescent Peripheral Blood Mononuclear Cells from Producing Human Immunodeficiency Virus by Borvak, Jozef, Chou, Chin-Sheng, Van Dyke, Gregory, Rosenwirth, Brigitte, Vitetta, Ellen S., Ramilo, Octavio

    Published in The Journal of infectious diseases (01-10-1996)
    “…It has been shown that the combined use of two pharmacologic agents can inhibit human immunodeficiency virus (HIV) production by peripheral blood mononuclear…”
    Get full text
    Journal Article